ArticleJournal of anaesthesiology, clinical pharmacology

Intraoperative use of dexmedetomidine is associated with decreased overall survival after lung cancer surgery.

Juan P Cata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.